对阿尔茨海默氏病遗传和零星形式的空间和单核转录组分析
Emily Miyoshi1,2, Samuel Morabito2,3,4, Caden M Henningfield1,2
1Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA, USA.
bioRxiv : the preprint server for biology
|August 7, 2023
概括
这项研究使用空间转录学绘制了阿尔茨海默病 (AD) 基因表达变化的脑图. 在偶尔的AD和唐氏综合征的AD中发现了类似的分子模式,将基因活性与粉样蛋白病理联系起来.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括复杂的遗传和环境相互作用,导致分子变异性.
- 了解AD转录组对于弥合小鼠模型和人类零星AD (sAD) 之间的差距至关重要.
研究的目的:
- 使用空间转录组学 (ST) 和单核RNA-seq.进行对阿尔茨海默病 (AD) 的综合转录组学调查.
- 研究早期的AD,晚期的AD和唐氏综合征的AD (AD in DS) 的空间和细胞类型特定的分子变化.
- 通过分析来自5xFAD小鼠模型的ST数据并将基因表达与粉样蛋白病理学联系起来,使跨物种比较成为可能.
主要方法:
- 在人类皮质样本上的空间转录学 (ST) 和单核RNA-seq (早期AD,晚期AD,DS中的AD).
- 在5xFAD和野生型小鼠模型上进行ST实验,跨越疾病时间.
- 在用于ST的相同组织样本上进行粉样质斑块和纤维素成像.
主要成果:
- 在AD中识别空间和细胞类型特定的转录组变化.
- 在这些变化中,零星AD (sAD) 和唐氏综合征AD (DS中的AD) 之间的广泛相似性的证明.
- 在基因表达改变和粉样斑块积累/扩散之间确立了直接的相关性.
结论:
- 空间转录学为剖析阿尔茨海默病分子格局提供了一个强大的工具.
- 唐氏综合征的AD作为一种有价值的模型,用于理解零星的AD转录学.
- 基因表达的变化直接与AD大脑中粉样蛋白病理的积累和传播有关.
相关概念视频
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215


